A Randomized, Evaluator-blinded, Bilateral Comparison of the Treatment of Facial Actinic Keratoses Using Combination Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Different Incubation Times
Phase of Trial: Phase IV
Latest Information Update: 22 Jul 2017
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 18 Jul 2017 Status changed from active, no longer recruiting to completed.
- 17 Feb 2017 Planned End Date changed from 1 Dec 2016 to 30 Apr 2017.
- 07 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 30 Apr 2017.